Loading...
•
Mar 31
Elanco Q1 2025 Earnings Report
Elanco Animal Health reported financial results for the first quarter of 2025, exceeding guidance for revenue, adjusted EBITDA, and adjusted EPS.
Key Takeaways
Elanco Animal Health reported first quarter 2025 revenue of $1,193 million, a 1% decrease year-over-year but a 4% increase in organic constant currency. The company reported net income of $67 million and adjusted net income of $184 million. Reported EPS was $0.13 and adjusted EPS was $0.37. The company raised its full-year 2025 revenue guidance.
First quarter 2025 revenue was $1,193 million, a 1% decrease year-over-year but a 4% increase in organic constant currency.
Reported Net Income was $67 million, and Adjusted Net Income was $184 million.
Reported EPS was $0.13, and Adjusted EPS was $0.37.
Elanco is raising full-year 2025 revenue guidance to $4,510 to $4,580 million.
Elanco
Elanco
Elanco Revenue by Segment
Revenue by Segment
Pet Health Revenue
CapyFin.comFarm Animal Revenue
CapyFin.comCattle Revenue
CapyFin.comPoultry Revenue
CapyFin.comSwine Revenue
CapyFin.comContract Manufacturing & Other Revenue
CapyFin.com Forward Guidance
Elanco is raising its full year 2025 revenue guidance to $4,510 to $4,580 million and maintaining adjusted EBITDA and adjusted EPS guidance.
Positive Outlook
- Raising 2025 revenue guidance driven by foreign exchange tailwind and strong first quarter performance.
- Increasing 2025 innovation revenue target to $660 to $740 million.
- Expecting accelerating organic constant currency revenue growth to mid-single digits.
- Expecting gross debt paydown of $450 to $500 million in 2025.
- 2025 year-end net leverage ratio target improved to 3.9x to 4.3x.
Challenges Ahead
- Reported Net Loss of $(35) to $(7) million expected for the full year.
- Reported Loss Per Share of $(0.07) to $(0.01) expected for the full year.
- Outlook incorporates current estimate for tariff net impact of $16 to $20 million to Adjusted EBITDA.
- Expected continued macro volatility factored into outlook.
- Second quarter guidance anticipates approximately $5 million headwind to revenue from unfavorable foreign exchange rates.
Revenue & Expenses
Visualization of income flow from segment revenue to net income